Status:
COMPLETED
Long-term Varenicline Treatment for Smoking Cessation
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
Pfizer
Conditions:
Smoking
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
This is a clinical study of the efficacy and safety of up to 52 weeks of varenicline therapy in conjunction with individual counseling for smoking cessation. Adult volunteers in generally good health,...
Eligibility Criteria
Inclusion
- daily smoker
- 5+ cigarettes per day for at least one year
- expired carbon monoxide level of 5+ ppm
Exclusion
- current use of smoking cessation pharmacotherapies
- current or history of psychotic disorder
- current major depressive disorder
- history of suicidal ideation in the previous 3 months
- unstable medical condition
- pregnant, nursing, or planning to become pregnant
- planning to move from study area within 18 months
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT00828113
Start Date
January 1 2009
End Date
February 1 2011
Last Update
November 20 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Tobacco Research and Intervention
Madison, Wisconsin, United States, 53711
2
Center for Tobacco Research and Intervention
Milwaukee, Wisconsin, United States, 53233